Long-term Outcomes of Boston Type I Keratoprosthesis, and Efficacy of Amphotericin B and Povidone-Iodine in Infection Prophylaxis.

American Journal of Ophthalmology
Pinnita PrabhasawatWarinyupa Pinitpuwadol

Abstract

To evaluate the long-term outcomes, anatomic retention, and complications of Boston type I keratoprosthesis (KPro). Retrospective, interventional case series METHODS: A retrospective chart review of implantations performed January 2008-December 2017 was conducted. Risk factors for anatomical retention and functional success were analyzed. The incidences of infections with and without antimicrobial medications were compared. Twenty-seven eyes of 26 patients were recruited. The most common indication for KPro surgery was failed penetrating keratoplasties (22 eyes, 81.5%). All patients had preoperative best-corrected visual acuity (BCVA) worse than 3/60. Over the mean follow-up of 83.4 ± 28.4 months, 15 eyes (55.6%) demonstrated improved BCVA. The anatomical retention rate was 88.9%, and the functional success rate was 44.4% (retained KPro with BCVA ≥ 3/60). Eyes with ocular surface disease (OSD) had significantly more complications than those without OSD. The most common complications were retroprosthetic membrane formation (15 eyes, 55.6%) and infection (13 eyes, 48.1%). Infectious keratitis was primarily caused by gram-positive bacteria, whereas endophthalmitis was chiefly caused by fungal infection. The infection incidence was...Continue Reading

References

May 1, 1974·American Journal of Ophthalmology·C H DohlmanM G Doane
Apr 17, 1998·Ophthalmology·P A NetlandC H Dohlman
Feb 24, 2001·Cornea·F YaghoutiC H Dohlman
Apr 25, 2001·Archives of Ophthalmology·M NouriC H Dohlman
Jul 29, 2006·Ophthalmology·Brian L ZerbeUNKNOWN Boston Type 1 Keratoprosthesis Study Group
Apr 24, 2007·International Ophthalmology Clinics·Bilal F KhanClaes H Dohlman
Sep 3, 2009·Cornea·Hall F ChewElisabeth J Cohen
Jan 26, 2010·Ophthalmology·Karen DunlapEsen Akpek
Dec 31, 2010·Current Opinion in Ophthalmology·Michael Banitt
Feb 9, 2012·Cornea·Clara C Chan, Edward J Holland
Mar 1, 2012·Ophthalmology·Christopher J RudniskyUNKNOWN Boston Type 1 Keratoprosthesis Study Group
Apr 20, 2012·Ophthalmology·Anthony J AldaveFei Yu
May 19, 2012·Journal of Glaucoma·Joseph F PanarelliMichael R Banitt
Aug 9, 2012·Arquivos brasileiros de oftalmologia·Fernanda Pedreira MagalhãesLauro Augusto de Oliveira
Feb 15, 2013·Acta Ophthalmologica·Fernanda Pedreira MagalhãesLauro Augusto de Oliveira
Mar 19, 2013·Ophthalmology·Joseph B CiolinoUNKNOWN Boston Keratoprosthesis Type 1 Study Group
Feb 14, 2015·Clinical & Experimental Optometry : Journal of the Australian Optometrical Association·Duane R GeruschatJessy Dorn
May 7, 2015·Clinical Ophthalmology·Venkata S AvadhanamChristopher Liu
Mar 31, 2017·Clinical Microbiology Reviews·Marlene L Durand
May 23, 2017·Current Ophthalmology Reports·Thasarat S VajaranantAhmad A Aref
Jul 24, 2020·The Ocular Surface·Levi N KanuMaria S Cortina
Sep 12, 2020·The Ocular Surface·Jennifer ParkM Soledad Cortina

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.